ImmunXperts

Foundation date

15/05/2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmunXperts offers a wide range of in silico and in vitro assays to companies developing new drugs. The purpose of these tests is to help our partners select the best and less risky drug candidates before further development into the clinical phases. We want to be a trusted partner for our clients by thinking and working together; acting as their mobile development team in the areas where they need us.

Upcoming events

Latest news

  • Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

    1 day ago

  • Celyad announces management change

    Friday December 1st 2023

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023